USPTO serial 88873545
CELL FOUNDRIES
Reviewed by CopyMark Law Group
Status 603
- Filing date
- Status date
- Registration date
- —
- Examiner
- FERRELL, LUCY K
- Law office
- TMO LAW OFFICE 126- EXAMINING ATTORNEY ASSIGNED
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with CELL FOUNDRIES?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
South San Francisco, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
SEAN PLOEN
Sean Ploen PLOEN LAW FIRM, PC1595 SELBY AVE, SUITE 300ST. PAUL, MN 55104UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical, biological and biochemical products for industrial and scientific purposes, other than for medical purposes, namely, biological tissue cultures for industrial and scientific purposes and not for medical or veterinary purposes; reagents for scientific and research use | ACTIVE | — |
| 009 | Downloadable computer software for accessing a database featuring information in the medical field, specifically, stem cell therapy related information; Downloadable software applications for telephones, tablets, computers, namely, software for allowing the access to information and consulting in the field of health; Downloadable software applications for telephones, tablets, computers, namely, software for allowing the access to information, monitoring and management systems for the manufacture of advanced therapy and cell therapy medications; Downloadable databases in the field of manufacture of advanced therapy and cell therapy medications; downloadable electronic publications in the nature of electronic questionnaires on the area of advanced therapy and cell therapy medications; none of the foregoing in the field of pharmaceutical and veterinary products | ACTIVE | — |
| 010 | Medical equipment for the manufacturing of autologous and allogeneic biological cell therapies for medical and non-veterinary purposes, namely, fully integrated system for use in the creation of biological cell therapies for medical purposes and disposable single-use containers, namely, bags, pouches, cartridges, rigid and semi-rigid containers for concentrates and solutions in solid or liquid form in the nature of contaminated medical waste for medical use | ACTIVE | — |
| 037 | Installation, repair and maintenance services of medical and scientific equipment for the manufacturing of autologous and allogeneic biological cell therapies | ACTIVE | — |
| 040 | Custom manufacture of therapeutic drugs by pharmaceutical compounders in the field of cell therapies and cancer therapies; custom manufacturing for others, namely, manufacturing of pharmaceutical and veterinary preparations by pharmaceutical compounders for health care for the treatment of humans and animals suffering from diseases treated by cell therapy or regenerative medicine products, namely, medicines for human purposes, medicines for experimental purposes, biological pharmaceuticals for experimental purposes, pharmaceuticals for cell therapy and medicines for innovative therapies | ACTIVE | — |
| 042 | Research and development services in the field of cell therapies; Scientific research in the field of human and animal cell therapy; Providing a bioinformatics platform as a service (PAAS) featuring computer software for sequence data analysis in the field of manufacturing therapeutics; Medical and scientific research information in the field of cell therapy; Medical and scientific research in the field of cell therapy; technical assessments relating to design, namely, technical design consultation in the field of manufacture of advanced therapy and cell therapy medications; Technical research in the field of manufacture of advanced therapy and cell therapy medications; Software as a service (SaaS) services featuring software for assisting in the diagnosis of medical conditions in relation to advanced therapy and cell therapy medications; Cloud computing featuring software for use in assisting in the diagnosis of medical conditions; Providing search engines for the internet in the medical field and manufacturing of advanced therapy and cell therapy medications fields; Computer services, namely, the creation of websites for others used for registered users of virtual communities that allows the organization of groups and events, the participation to discussion, and the involvement into the social, business and community networking in the medical field and manufacturing of advanced therapy and cell therapy medications fields; Computer services, namely, hosting of electronic online web facilities for third parties to organize colloquiums, events and interactive discussions via communication networks in the medical field and manufacturing of advanced therapy and cell therapy medications fields; Hosting digital content for users on the Internet in the medical field and manufacturing of advanced therapy and cell therapy medications fields; Designing web pages for others, namely, online forums in the field of manufacture of advanced therapy and cell therapy | ACTIVE | — |
| 044 | Stem cell therapy services; autologous and allogeneic cell therapy services for medical treatment purposes, namely, genetic testing of humans for health assessment, diagnostic or treatment purposes, all for medical purposes; autologous and allogeneic cell therapy services for the treatment of hematological malignancies; medical services, namely, administration of cell therapy services for the treatment of hematological malignancies | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Cellares Corporation
- Other trademarks in Class 001
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 037
- Other trademarks in Class 040
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named CELL FOUNDRIES
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 11, 2022 | MAB3 | ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL | — |
| Jan 11, 2022 | ABN3 | ABANDONMENT - AFTER EX PARTE APPEAL | — |
| Jan 11, 2022 | EXPT | EXPARTE APPEAL TERMINATED | — |
| Nov 29, 2021 | EXFB | EXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF | — |
| Sep 29, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 16, 2021 | GEA1 | NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED | — |
| Sep 16, 2021 | GECD | ACTION DENYING REQ FOR RECON E-MAILED | — |
| Sep 16, 2021 | CNCF | ACTION CONTINUING FINAL - COMPLETED | — |
| Aug 16, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 16, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 13, 2021 | ALIE | ASSIGNED TO LIE | — |
| Aug 10, 2021 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Aug 10, 2021 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Aug 10, 2021 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Aug 10, 2021 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Feb 10, 2021 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Feb 10, 2021 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Feb 10, 2021 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jan 11, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 11, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 11, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 14, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 14, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 14, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 6, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 23, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 18, 2020 | NWAP | NEW APPLICATION ENTERED | — |